Glazener Ethan M, Lodin Kenneth, Miller Michael J, Frager Matthew J, Rahimian Javad, Chen Joseph C T, Girvigian Michael R
Department of Radiation Oncology, Kaiser Permanente, Los Angeles, California.
Neurorestoration Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
Adv Radiat Oncol. 2020 Apr 13;5(5):850-855. doi: 10.1016/j.adro.2020.03.018. eCollection 2020 Sep-Oct.
To analyze and report the long-term outcomes of intracranial arteriovenous malformations (AVM) treated with linear accelerator (LINAC)-based radiosurgery (LBRS) in the pediatric population.
A series of 34 pediatric patients (≤18 years old) who were treated between 2002 and 2016 were analyzed. All patients were treated with LBRS in a single fraction, with a median dose of 16.8 Gy to the 80% isodose line. Median age at treatment was 14.4 years (range 5.5-18.9). Median AVM volume was 2.91 mL (range 0.228-27.313). Median modified radiosurgery-based AVM score was 0.83 (range 0.18-2.96). The most common presenting symptom was intracranial hemorrhage (ICH) (n = 22, 64.7%). Nine patients underwent intervention before LBRS, which included prior embolization or resection. Seven lesions were in eloquent locations, defined as basal ganglia, thalamus, or brainstem. Cerebral angiography was done to confirm obliteration.
Median follow-up time was 98 months (range 36-200 months). Twenty-two of the 34 lesions were obliterated (64.7%) with median time to obliteration of 37 months (range 14-79). No deaths occurred during the follow up period; however, two patients experienced ICH after treatment. Three other patients were treated for symptomatic radiation necrosis.
Treatment of intracranial AVM with LBRS in the pediatric population is demonstrated to be safe and effective with long-term follow up.
分析并报告基于直线加速器(LINAC)的放射外科治疗(LBRS)小儿颅内动静脉畸形(AVM)的长期疗效。
分析了2002年至2016年间接受治疗的34例儿科患者(≤18岁)。所有患者均接受单次分割的LBRS治疗,80%等剂量线的中位剂量为16.8 Gy。治疗时的中位年龄为14.4岁(范围5.5 - 18.9岁)。AVM的中位体积为2.91 mL(范围0.228 - 27.313 mL)。基于放射外科的改良AVM评分中位值为0.83(范围0.18 - 2.96)。最常见的临床表现为颅内出血(ICH)(n = 22,64.7%)。9例患者在LBRS治疗前接受了干预,包括先前的栓塞或切除术。7个病灶位于功能区,定义为基底节、丘脑或脑干。进行脑血管造影以确认闭塞情况。
中位随访时间为98个月(范围36 - 200个月)。34个病灶中有22个(64.7%)闭塞,闭塞的中位时间为37个月(范围14 - 79个月)。随访期间无死亡病例;然而,2例患者在治疗后发生ICH。另外3例患者因放射性坏死症状接受治疗。
长期随访表明,LBRS治疗小儿颅内AVM安全有效。